SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006101
Filing Date
2021-05-06
Accepted
2021-05-06 09:10:49
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20210331x10q.htm   iXBRL 10-Q 923124
2 EX-10.1 albo-20210331xex10d1.htm EX-10.1 25165
3 EX-31.1 albo-20210331xex31d1.htm EX-31.1 10372
4 EX-31.2 albo-20210331xex31d2.htm EX-31.2 10337
5 EX-32.1 albo-20210331xex32d1.htm EX-32.1 10533
  Complete submission text file 0001558370-21-006101.txt   3481524

Data Files

Seq Description Document Type Size
6 EX-101.SCH albo-20210331.xsd EX-101.SCH 29842
7 EX-101.CAL albo-20210331_cal.xml EX-101.CAL 28880
8 EX-101.DEF albo-20210331_def.xml EX-101.DEF 82119
9 EX-101.LAB albo-20210331_lab.xml EX-101.LAB 267951
10 EX-101.PRE albo-20210331_pre.xml EX-101.PRE 187544
11 EXTRACTED XBRL INSTANCE DOCUMENT albo-20210331x10q_htm.xml XML 414004
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 21896135
SIC: 2834 Pharmaceutical Preparations